uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors
H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA..
Univ Kentucky, Markey Canc Ctr, Lexington, KY USA..
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA..
Dana Farber Canc Inst, Boston, MA 02115 USA..
Show others and affiliations
2017 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 105, p. 257-257Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
KARGER , 2017. Vol. 105, p. 257-257
Keywords [en]
177lu-dotatate, prrt, net, quality of life
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-346592ISI: 000413957900258OAI: oai:DiVA.org:uu-346592DiVA, id: diva2:1191814
Conference
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 08-10, 2017, Barcelona, SPAIN
Available from: 2018-03-20 Created: 2018-03-20 Last updated: 2018-03-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Öberg, Kjell

Search in DiVA

By author/editor
Öberg, Kjell
By organisation
Endocrine Tumor Biology
In the same journal
Neuroendocrinology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 11 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf